Benefits of treatment with SGLT2i and GLP-1RA based on their direct and indirect metabolic, cardiovascular, and renal effects. SGLT2i: Sodium-glucose cotransporter-2 inhibitors, GLP-1RA: Glucagon-like peptide-1 receptor agonists.
Untitled
Benefits of treatment with SGLT2i and GLP-1RA based on their direct and indirect metabolic, cardiovascular, and renal effects. SGLT2i: Sodium-glucose cotransporter-2 inhibitors, GLP-1RA: Glucagon-like peptide-1 receptor agonists.
Leave a Reply